| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |